- Original Article
- Cardiology
- Clinical outcome of patients with refractory Kawasaki disease based on treatment modalities
-
Hyun Jung Kim, Hyo Eun Lee, Jae Won Yu, Hong Ryang Kil
-
Clin Exp Pediatr. 2016;59(8):328-334. Published online August 24, 2016
-
|
Purpose Although a significant number of reports on new therapeutic options for refractory Kawasaki disease (KD) such as steroid, infliximab, or repeated intravenous immunoglobulin (IVIG) are available, their effectiveness in reducing the prevalence of coronary artery lesions (CAL) remains controversial. This study aimed to define the clinical characteristics of patients with refractory KD and to assess the effects of adjuvant therapy... |
-
-
|